New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

about

Umbilical cord blood transplantation supplemented with the infusion of mesenchymal stem cell for an adolescent patient with severe aplastic anemia: a case report and review of literature Rapamycin targets several pathophysiological features of immune-mediated bone marrow failure in murine models.

P2860

Q35746929-00AF440A-3FD4-40DA-9EB0-DAFAC2BC37D9 Q42368313-2A5BFF78-53F4-44C2-9E70-FF5B90069292

P2860

New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

Item

http://www.wikidata.org/entity/Q38160780

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

@en

type

Item

label

New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

@en

prefLabel

New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

@en

P1476

New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia

@en

P2093

Rebecca Adkins

http://www.w3.org/2001/XMLSchema#string

Roland Jurecic

http://www.w3.org/2001/XMLSchema#string

Vineet Gupta

http://www.w3.org/2001/XMLSchema#string

P2860

Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells

Current concepts in the pathophysiology and treatment of aplastic anemia

Integrins: bidirectional, allosteric signaling machines

CD18 trials disappoint again

Targeting leukocyte integrins in human diseases

Getting to the site of inflammation: the leukocyte adhesion cascade updated

SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells

Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.

Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease.

Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients.

P2888

s12026-013-8449-0

P304

34-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12026-013-8449-0

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wendy W Weston

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012697738

http://www.w3.org/2001/XMLSchema#string

P698

24203441

http://www.w3.org/2001/XMLSchema#string

New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

about

P2860

P2860

New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698